Profile data is unavailable for this security.
About the company
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.
- Revenue in USD (TTM)23.30m
- Net income in USD-80.59m
- Incorporated2015
- Employees132.00
- LocationSenseonics Holdings Inc20451 Seneca Meadows PkwyGERMANTOWN 20876-7005United StatesUSA
- Phone+1 (301) 515-7260
- Fax+1 (302) 655-5049
- Websitehttps://www.senseonics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | 42.09m | -52.01m | 179.03m | 200.00 | -- | 2.70 | -- | 4.25 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 186.45m | 56.00 | -- | 3.26 | -- | 84.14 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Outset Medical Inc | 125.08m | -168.77m | 186.64m | 480.00 | -- | 2.00 | -- | 1.49 | -3.38 | -3.38 | 2.50 | 1.80 | 0.3529 | 1.82 | 3.53 | 260,577.10 | -47.61 | -41.40 | -54.98 | -47.29 | 24.61 | 5.71 | -134.93 | -159.05 | 5.32 | -32.13 | 0.6786 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| Inogen Inc | 321.52m | -96.68m | 208.19m | 834.00 | -- | 1.08 | -- | 0.6475 | -4.15 | -4.15 | 13.81 | 8.15 | 0.917 | 6.03 | 6.83 | 385,519.20 | -27.57 | -8.23 | -34.28 | -9.53 | 40.54 | 44.54 | -30.07 | -10.31 | 2.36 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Delcath Systems Inc | 4.61m | -49.79m | 210.33m | 76.00 | -- | 13.17 | -- | 45.65 | -2.65 | -2.65 | 0.2357 | 0.5747 | 0.1382 | 0.4545 | 4.56 | 60,618.42 | -149.30 | -116.57 | -249.28 | -243.21 | 70.54 | 71.02 | -1,080.73 | -1,235.37 | 2.25 | -42.25 | 0.3348 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Butterfly Network Inc | 68.08m | -121.92m | 217.03m | 225.00 | -- | 1.06 | -- | 3.19 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Neuropace Inc | 69.07m | -31.51m | 235.04m | 171.00 | -- | 16.36 | -- | 3.40 | -1.18 | -1.18 | 2.59 | 0.4994 | 0.6735 | 1.62 | 6.63 | 403,935.70 | -30.72 | -- | -34.60 | -- | 73.97 | -- | -45.61 | -- | 5.56 | -4.67 | 0.8019 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| AngioDynamics, Inc. | 324.01m | -192.37m | 241.93m | 815.00 | -- | 1.12 | -- | 0.7467 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Utah Medical Products, Inc. | 49.04m | 16.38m | 246.00m | 169.00 | 15.46 | 1.96 | 11.38 | 5.02 | 4.51 | 4.51 | 13.50 | 35.60 | 0.3727 | 2.09 | 13.24 | 290,201.20 | 12.44 | 12.69 | 13.02 | 13.19 | 59.05 | 61.57 | 33.39 | 30.51 | 17.89 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| Edap Tms SA (ADR) | 65.68m | -23.02m | 248.97m | 307.00 | -- | 4.02 | -- | 3.79 | -0.6224 | -0.6224 | 1.78 | 1.67 | 0.6272 | 2.68 | 3.86 | 213,941.50 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Senseonics Holdings Inc | 23.30m | -80.59m | 257.50m | 132.00 | -- | 13.58 | -- | 11.05 | -0.1354 | -0.1354 | 0.039 | 0.1067 | 0.1635 | 2.51 | 6.51 | 176,515.20 | -56.55 | -73.65 | -66.90 | -106.97 | 12.93 | -40.41 | -345.89 | -649.86 | 3.70 | -11.13 | 0.4783 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| AxoGen Inc | 163.73m | -21.28m | 263.98m | 426.00 | -- | 2.83 | -- | 1.61 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Sight Sciences Inc | 81.50m | -54.75m | 265.70m | 214.00 | -- | 2.42 | -- | 3.26 | -1.12 | -1.12 | 1.67 | 2.20 | 0.4628 | 1.66 | 5.09 | 380,822.40 | -31.09 | -38.78 | -33.65 | -42.20 | 85.73 | 80.74 | -67.18 | -105.14 | 12.42 | -14.76 | 0.2358 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Treace Medical Concepts Inc | 196.03m | -54.75m | 310.04m | 516.00 | -- | 2.45 | -- | 1.58 | -0.8885 | -0.8885 | 3.18 | 2.04 | 0.797 | 1.28 | 7.07 | 379,905.00 | -22.26 | -- | -25.98 | -- | 80.99 | -- | -27.93 | -- | 3.22 | -- | 0.2958 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Tactile Systems Technology Inc | 276.67m | 28.19m | 326.25m | 992.00 | 11.61 | 1.69 | 9.39 | 1.18 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
Data as of May 17 2024. Currency figures normalised to Senseonics Holdings Inc's reporting currency: US Dollar USD
10.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 22.34m | 4.21% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 11.77m | 2.22% |
| Masters Capital Management LLCas of 31 Mar 2024 | 7.00m | 1.32% |
| Geode Capital Management LLCas of 31 Mar 2024 | 5.61m | 1.06% |
| Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 3.09m | 0.58% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.89m | 0.36% |
| AXA Investment Managers UK Ltd.as of 31 Mar 2024 | 1.20m | 0.23% |
| Point72 Asset Management LPas of 31 Mar 2024 | 1.09m | 0.21% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 998.59k | 0.19% |
| Global X Management Co. LLCas of 31 Mar 2024 | 909.93k | 0.17% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
